Dendrimers for vaccine and immunostimulatory uses. A review.
about
Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applicationsImmunomodulation of nanoparticles in nanomedicine applicationsSynthesis, structure and molecular modelling of anionic carbosilane dendrimers.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.Clusters of ligands on dendrimer surfaces.Enhanced bioactivity of internally functionalized cationic dendrimers with PEG coresCarbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.Recent trends in vaccine delivery systems: A review.A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity.A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.N-acetylgalactosamino dendrons as clearing agents to enhance liver targeting of model antibody-fusion protein.Biomedical applications of dendrimers: a tutorial.Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.Nanomaterials: applications in cancer imaging and therapy.Guiding principles in the design of molecular bioconjugates for vaccine applications.Recent advances in vaccine delivery.Peptide-Decorated Dendrimers and Their Bioapplications.Dendrimer-based nanocarriers: a versatile platform for drug delivery.Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.Conjugated anionic PEG-citrate G2 dendrimer with multi-epitopic HIV-1 vaccine candidate enhance the cellular immune responses in mice.Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.End-group distributions of multiple generations of spin-labeled PAMAM dendrimers.Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials.Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle.Study of cationic carbosilane dendrimers as potential activating stimuli in macrophagesApplications of Dendrimers in Drug Delivery Agents, Diagnosis, Therapy, and DetectionInhibition of the norepinephrine transporter by χ-conotoxin dendrimersApplication of Dendrimers for the Treatment of Infectious Diseases
P2860
Q26771189-ADDBE7B6-3E88-4018-83FE-18252E36525DQ27021145-1085CBEB-4095-42A7-B960-FF8867D4912CQ30564353-05B82B99-9147-46B7-BBFD-EFB06DED8D0AQ33740696-84BC002A-F052-44A4-8F4E-AFDCA38F262EQ33792946-53A09A88-B444-4DCF-AE48-A392069C11F3Q33882982-9EB93236-4C88-4A15-A1BF-F77C34685BDAQ34472589-606F68AA-54CB-425F-89A6-6DEF28FEC5BEQ34478719-2BC710A2-7993-45C6-B7C6-16C78A5AD1CDQ36300181-4BA97CFA-037A-45BA-8AF4-DF80A450230AQ36604334-D36D82D7-52AD-4C4C-A180-87943B41B8AEQ36630332-7EEFF2E8-344E-4D06-9883-2ECF87D745DBQ36690711-154C6066-F3BC-455C-889D-81FAB714EEF2Q37076109-EA2CB5B3-24C0-4E02-A87D-5B62137AF44AQ37509342-7C8FBBA0-187F-4C0D-8810-3D224E7D5761Q37793942-D743DEA5-237A-4693-870D-C90EE4C602F4Q37834084-E566F39D-E655-4FAF-B3C3-50C368B193BEQ37857064-0EBFED8A-D433-4B15-BF31-1BCCC293D618Q38395963-B3A9DEEC-E65E-41BA-A0FC-96124FF33BF0Q38669255-74D10812-121D-4B8A-922F-B8154EBAE70DQ38779839-46B3F53B-2183-434E-82F9-2215FB5BA4E7Q38820422-0776D55C-6CEA-4256-A334-A601480BCA37Q39375757-AD075DD8-A5E8-43AB-8F26-FF62FC437CA0Q39885075-9F0E09AC-290B-410A-888D-A16E05876B70Q40299563-5BB68E16-FB86-4E7C-8B4B-3578530B4ABCQ41806887-D2D07D53-F557-48F0-8AD8-8D4BC79FCD2BQ41874628-4768B486-18DF-488B-A107-E5F44C69CA45Q46429495-6F6A5966-39A6-4402-B52C-199B329529A3Q49963085-08E7DB12-68E3-42C9-915F-47E06DC5C703Q50506338-7334ADBC-2AF8-4683-B016-FFE92DAD07BDQ55031351-7D5E0994-C8E4-48A1-A4DE-3FB736286FF2Q57079942-2BFD7D65-F801-4A9A-B9AA-3293A4C64BE9Q57380327-B72B1284-7ACE-40CC-8040-D6DE1A7FF354Q58284339-25EC44D0-1948-4EC8-8931-5C767969EC8CQ58696083-6653ECFA-0202-4313-A637-E8D2E3CFF57C
P2860
Dendrimers for vaccine and immunostimulatory uses. A review.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dendrimers for vaccine and immunostimulatory uses. A review.
@en
Dendrimers for vaccine and immunostimulatory uses. A review.
@nl
type
label
Dendrimers for vaccine and immunostimulatory uses. A review.
@en
Dendrimers for vaccine and immunostimulatory uses. A review.
@nl
prefLabel
Dendrimers for vaccine and immunostimulatory uses. A review.
@en
Dendrimers for vaccine and immunostimulatory uses. A review.
@nl
P356
P1476
Dendrimers for vaccine and immunostimulatory uses. A review
@en
P2093
Nanna Skall Sorensen
Ulrik Boas
P304
P356
10.1021/BC900290D
P577
2009-11-04T00:00:00Z